EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice

Remo Castro Russo iD, Bernhard Ryffel iD

Cells · 12.12.2024 · 13 (24) · 2058

DOI: 10.3390/cells13242058 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 12.12.2024. Verfasst von Remo Castro Russo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pulmonary Immunology and Mechanics, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de …. Hauptthemen laut MEDLINE: Bleomycin, Idiopathic Pulmonary Fibrosis, Chemokines, Disease Models, Animal. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 391 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo a Pesquisa de Minas Gerais (FAPEMIG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic and lethal interstitial lung disease (ILD) of unknown origin, characterized by limited treatment efficacy and a fibroproliferative nature. It is marked by excessive extracellular matrix deposition in the pulmonary parenchyma, leading to progressive lung volume decline and impaired gas exchange. The chemokine system, a network of proteins involved in cellular communication with diverse biological functions, plays a crucial role in various respiratory diseases. Chemokine receptors trigger the activation, proliferation, and migration of lung-resident cells, including pneumocytes, endothelial cells, alveolar macrophages, and fibroblasts. Around 50 chemokines can potentially interact with 20 receptors, expressed by both leukocytes and non-leukocytes such as tissue parenchyma cells, contributing to processes such as leukocyte mobilization from the bone marrow, recirculation through lymphoid organs, and tissue influx during inflammation or immune response. This narrative review explores the complexity of the chemokine system in the context of IPF and the bleomycin-induced lung fibrosis mouse model. The goal is to identify specific chemokines and receptors as potential therapeutic targets. Recent progress in understanding the role of the chemokine system during IPF, using experimental models and molecular diagnosis, underscores the complex nature of this system in the context of the disease. Despite advances in experimental models and molecular diagnostics, discovering an effective therapy for IPF remains a significant challenge in both medicine and pharmacology. This work delves into microarray results from lung samples of IPF patients and murine samples at different stages of bleomycin-induced pulmonary fibrosis. By discussing common pathways identified in both IPF and the experimental model, we aim to shed light on potential targets for therapeutic intervention. Dysregulation caused by abnormal chemokine levels observed in IPF lungs may activate multiple targets, suggesting that chemokine signaling plays a central role in maintaining or perpetuating lung fibrogenesis. The highlighted chemokine axes (CCL8-CCR2, CCL19/CCL21-CCR7, CXCL9-CXCR3, CCL3/CCL4/CCL5-CCR5, and CCL20-CCR6) present promising opportunities for advancing IPF treatment research and uncovering new pharmacological targets within the chemokine system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BleomycinIdiopathic Pulmonary FibrosisChemokinesDisease Models, AnimalAnimalsHumansMiceReceptors, ChemokineLungSignal Transduction

Stichwörter der Autor:innen

chemokineidiopathic pulmonary fibrosisinterstitial lung diseasemucosal immunologytherapeutic targets

Substanzen

BleomycinChemokinesReceptors, Chemokine

Autor:innen und Institutionen

  • Laboratory of Pulmonary Immunology and Mechanics, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais-UFMG, Belo Horizonte 31270-901, MG, Brazil.
  • Laboratory of Immuno-Neuro Modulation (INEM), UMR7355 Centre National de la Recherche Scientifique (CNRS), University of Orleans, 45071 Orleans, France.

ORCID-Profile: Remo Castro Russo, Bernhard Ryffel

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Fundação de Amparo a Pesquisa de Minas Gerais (FAPEMIG)
  • Le Studium Loire Valley - Institute for Advanced Studies
  • European funding in Region Centre-Val de Loire
  • Fundação de Amparo a Pesquisa de Minas Gerais (FAPEMIG) Edital Universal
  • Rede Mineira de Pesquisa Translacional em Imunobiológicos e Biofármacos no Câncer–REMITRIBIC
  • Le Studium Loire Valley–Institute for Advanced Studies (LE STUDIUM Visiting Researcher/ARD CVL Biopharmaceuticals 2023)

Zitieren

APA

Russo, R. C., & Ryffel, B. (2024). The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice. Cells, 13(24), 2058. https://doi.org/10.3390/cells13242058

Vancouver

Russo RC, Ryffel B. The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice. Cells. 2024;13(24):2058. doi:10.3390/cells13242058

BibTeX
@article{Russo2024,
  author = {Russo, Remo Castro and Ryffel, Bernhard},
  title = {The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {24},
  pages = {2058},
  doi = {10.3390/cells13242058}
}
Kostenlos starten →